Cell Isolation Market Is Estimated To Reach $16.4 Billion By 2025: Grand View Research, Inc.
The
global cell isolation/cell separation market is expected
to reach a value of USD 16.4 billion by 2025, according to a new report by
Grand View Research, Inc. Increasing demand for biopharmaceuticals including
antibodies, proteins, vaccines, and drugs is the most important factor that
drives the market growth during the forecast period. Biopharmaceuticals
development involves the application of various life science products such as
centrifuges, cell separator systems, flow cytometers, filtration systems, and
consumables. Thus, the demand for advanced cell isolation products by
biotechnology and biopharmaceutical companies is increasing, which is expected
to boost the market growth.
Rising
funding by biotechnology companies and government for cell-based research is
another major factor driving the growth of the cell isolation/cell separation
market. For instance, National Institutes of Health invested around USD 1,429
million for stem cells research in 2015. Stem cell therapy is the most
promising technique to treat severe medical conditions such as cancer,
cardiovascular disease, brain disease, and blood disease. Thus, the
biotechnology companies are adopting advanced cell separation products for the
research and development of stem cells.
U.S. cell
isolation market, by product, 2014 - 2025 (USD Million)
Browse full research report on Cell
Isolation Market: http://www.grandviewresearch.com/industry-analysis/cell-isolation-cell-separation-market
Further key findings from the study suggest:
- Consumables
product segment was the largest revenue-generating segment of the market
in the year 2016.
- Consumables
is expected to uphold its dominance during the forecast period owing to
repetitive purchase of these products for research and diagnostics
application
- The
human cells segment was the largest revenue grossing segment of the sector
in 2016, and is expected to grow at fastest rate due to growing demand of
isolated human cell in therapeutics, research, and biopharmaceuticals
production
- In 2016,
the centrifugation technique segment accounted for the largest share in
the overall market, owing to its wide application for manufacturing of
biopharmaceutical drugs, vaccines, proteins, and antibodies
- In
2016, North America dominated the overall market with the largest revenue
share due to the existence of major biopharmaceutical companies and
research laboratories in this region
- Asia
Pacific is projected to witness the highest CAGR over the forecast period,
owing to the mounting investments in cell-based research and rapidly
booming biotechnology industry in this region
- Some of
the key players include Thermo Fisher Scientific, Inc.; BD Biosciences; GE
Healthcare; Beckman Coulter, Inc.; Merck KGaA; Terumo BCT; STEMCELL
Technologies Inc.; and Bio-Rad Laboratories, Inc.
Access
Press Release By Grand View Research: http://www.grandviewresearch.com/press-release/global-cell-isolation-cell-separation-market
About
Grand View Research, Inc:
Grand View Research, Inc. is a U.S. based market
research and consulting company, registered in the State of California and
headquartered in San Francisco. The company provides syndicated research
reports, customized research reports, and consulting services. To help clients
make informed business decisions, the company offers market intelligence
studies ensuring relevant and fact-based research across a range of industries
including technology, chemicals, materials, healthcare and energy.
Comments
Post a Comment